Concurrent chemoradiation: Clinical Trials

5 trials of Concurrent chemoradiation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 2 unknown, 1 active not recruiting. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 2, Unknown 2, Active not recruiting 1

Follow Concurrent chemoradiation: new trials by email Literature Review of Concurrent chemoradiation trials Research Report on Concurrent chemoradiation

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer
Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab - Stomach Neoplasms, Esophagogastric Junction Disorder
Phase 2TerminatedFudan University62021-09-282025-06-18
Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma
Anlotinib hydrochloride, induction chemotherapy, concurrent chemoradiation - Nasopharyngeal Carcinoma
Phase 2UnknownZhejiang Cancer Hospital372021-01-012022-02-10
NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer
Pembrolizumab - NPC
Phase 2Active not recruitingChinese University of Hong Kong432019-05-032025-12-24
Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma
Radiotherapy alone, Concurrent chemoradiation - Extranodal NK/T-cell Lymphoma, Nasal Type
Phase 2TerminatedFudan University42012-06-012013-03-05
Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients
concurrent chemoradiation - Gastric Cancer
Phase 2UnknownChinese Academy of Medical Sciences402011-10-012015-02-05

Conditions studied

Stomach Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Nasopharyngeal Carcinoma (1)

Sponsors

Fudan University (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Chinese University of Hong Kong (1)  ·  Zhejiang Cancer Hospital (1)

Countries

China (4)  ·  Hong Kong (1)  ·  Singapore (1)

Top investigators

Ye Guo, MD (1)

Results publications

PMID 35764956